Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Federal Trade Commission
Mallinckrodt
Teva
Express Scripts
Healthtrust
Farmers Insurance
Citi
McKinsey

Generated: July 16, 2018

DrugPatentWatch Database Preview

COLISTIMETHATE SODIUM Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Colistimethate Sodium patents expire, and what generic alternatives are available?

Colistimethate Sodium is a drug marketed by Emcure Pharms Ltd, Fresenius Kabi Usa, Nexus Pharms, Sagent Pharms, X Gen Pharms, and Xellia Pharms Aps. and is included in six NDAs.

The generic ingredient in COLISTIMETHATE SODIUM is colistimethate sodium. There are two drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the colistimethate sodium profile page.
Summary for COLISTIMETHATE SODIUM
Drug patent expirations by year for COLISTIMETHATE SODIUM
Pharmacology for COLISTIMETHATE SODIUM

US Patents and Regulatory Information for COLISTIMETHATE SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Emcure Pharms Ltd COLISTIMETHATE SODIUM colistimethate sodium INJECTABLE;INJECTION 202359-001 Sep 28, 2012 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sagent Pharms COLISTIMETHATE SODIUM colistimethate sodium INJECTABLE;INJECTION 201365-001 Feb 19, 2014 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Fresenius Kabi Usa COLISTIMETHATE SODIUM colistimethate sodium INJECTABLE;INJECTION 065364-001 Apr 17, 2008 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Nexus Pharms COLISTIMETHATE SODIUM colistimethate sodium INJECTABLE;INJECTION 065177-001 Mar 19, 2004 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Queensland Health
Federal Trade Commission
Fish and Richardson
Medtronic
Citi
Merck
US Department of Justice
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.